MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
The Lancet
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,654 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,654 works in the cohort · of 4,299,418page 17 of 54

Labels cover 27 of 2,654 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,654 of 2,654 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
C. Jillian Tsai, Jonathan T. Yang, Narek Shaverdian, Juber Patel, Annemarie F. Shepherd, Juliana Eng +40 more
2023· article· en· The Lancet· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
255
citations
affno abstractunlabeled
Primary biliary cholangitis
Ana Lleò, Giu-Qiang Wang, M. Eric Gershwin, Gideon M. Hirschfield
2020· review· en· The Lancet· Medicine
distilled prediction:candidate · noneconsensus · none
251
citations
affno abstractunlabeled
Temporary circulatory support for cardiogenic shock
Alain Combes, Susanna Price, Arthur S. Slutsky, Daniel Brodie
2020· review· en· The Lancet· Engineering
distilled prediction:candidate · metaepi_narrowconsensus · none
248
citations
affno abstractunlabeled
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
Jonathan Spicer, Marina Chiara Garassino, Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi +15 more
2024· article· en· The Lancet· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
243
citations
affno abstractunlabeled
Counting the dead in Gaza: difficult but essential
Rasha Khatib, Martin McKee, Salim Yusuf
2024· letter· en· The Lancet· Health Professions
distilled prediction:candidate · research_integrity+insufficient_payloadconsensus · none
243
citations
affno abstractunlabeled
Iran in transition
2019· article· en· The Lancet· Social Sciences
distilled prediction:candidate · noneconsensus · none
243
citations
affno abstractunlabeled
Challenges in the management of the blood supply
Lorna M. Williamson, Dana V. Devine
2013· review· en· The Lancet· Business, Management and Accounting
distilled prediction:candidate · noneconsensus · none
240
citations
affno abstractunlabeled
An action agenda for HIV and sex workers
Chris Beyrer, Anna-Louise Crago, Linda‐Gail Bekker, Jenny Butler, Kate Shannon, Deanna Kerrigan +11 more
2014· review· en· The Lancet· Social Sciences
distilled prediction:candidate · noneconsensus · none
237
citations
affno abstractunlabeled
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
Scott A. Halperin, Lingyun Ye, Donna MacKinnon‐Cameron, Bruce R. Smith, Pedro Cahn, Guillermo M. Ruiz‐Palacios +42 more
2021· article· en· The Lancet· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
237
citations

How this was built: Screen · Findings · About